This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Roche
by Zacks Equity Research
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Roche
Achillion, J&J to Initiate Phase IIb Study on HCV Combo
by Zacks Equity Research
Achillion Pharmaceuticals, Inc. (ACHN) announced the initiation of patient dosing in a global phase IIb on JNJ-4178 ??? a triple combination of AL-335, odalasvir (also known as ACH-3102) and J&J's Olysio (simeprevir).
Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study
by Zacks Equity Research
Pfizer, Inc. (PFE) recently announced that its experimental biosimilar of Roche Holding AG's (RHHBY) breast cancer drug - Herceptin - has reached the primary endpoint in a pivotal study.
MedTech Industry Stock Outlook - December 2016
by Zacks Equity Research
The Republican win marked a great victory for the entire medical device industry as the likelihood of a permanent repeal of the 2.3% medical device excise tax will come as a big bonus.
J&J (JNJ) Stands Tall in 2016: Reasons for Outperformance
by Zacks Equity Research
Johnson & Johnson's (JNJ) share price is up 9.5% in the year-to-date period. This compares favorably with the 8.0% fall for the Zacks classified Large-Cap Pharma industry.
Stock Market News for November 28, 2016
by Zacks Equity Research
Company News for November 28, 2016
by Zacks Equity Research
Companies in the News are: JNJ,TAC,CTRP,NAVB,CAH
The Zacks Analyst Blog Highlights: Johnson & Johnson, Ascena Retail, Financial Sector, Industrials and Health care
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Ascena Retail, Financial Sector, Industrials and Health care
Trump Rotation Stocks to Buy Right Now
by David Bartosiak
The Trump Rotation has seen money flow into financials, healthcare and industrials but the opportunity is in retail
Stock Market News for November 08, 2016
by Zacks Equity Research
Benchmarks ended higher on Monday after the FBI said that it would not press criminal charges against Democratic nominee Hillary Clinton
The Zacks Analyst Blog Highlights: Johnson & Johnson, Wells Fargo, Facebook and Qualcomm
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Wells Fargo, Facebook and Qualcomm
Big Q3 Earnings Checklist, Plus Latest CPI
by Mark Vickery
We've got plenty of notable stocks reporting before the bell today, including many large financial institutions on Wall Street.
6 Healthcare Stocks Investors Cannot Miss in Q3 Earnings
by Zacks Equity Research
A number of healthcare companies are recording improvements in their financial numbers.
A Whole Lot of Nothing
by Sheraz Mian
Stocks haven't done much lately and the trend will likely continue for some time.
Is the Earnings Picture Improving?
by Sheraz Mian
There are some tell-tale signs of improvement in the aggregate earnings picture.
Is the Earnings Picture Improving?
by Sheraz Mian
There are some tell-tale signs of improvement in the aggregate earnings picture.
Stock Market News for July 20, 2016
by Zacks Equity Research
The Dow ended in the green for the eighth consecutive session on Tuesday following Johnson & Johnson's commendable quarterly performance
MedTech Industry Stock Outlook - July 2016
by Zacks Equity Research
Two full quarters of 2016 are behind us and, while we await second quarter results over the coming weeks, we hardly expect a change in trend in the bullish MedTech sector.
Stock Market News for June 03, 2016
by Zacks Equity Research
Benchmarks finished in the green on Thursday following encouraging U.S. private sector jobs data and gains in healthcare stocks
Hedge Funds Are Buying These Stocks, Should You?
by Jeremy Mullin
Following the smart money can lead to big gains.
Bear of the Day: AbbVie (ABBV)
by Kevin Cook
Estimates were already sliding before the Feds took up the patent fight by "hopeful rival" Coherus
3 Incredible Stocks Charts You Must See
by Tracey Ryniec
Beating the estimate 5 years in a row and shares at all time highs? No problem.
5 Skyrocketing Momentum Stocks
by David Bartosiak
Five red hot momentum stocks breaking out to new highs
Winning Stock Picks from the Top 5 Industries with the Biggest Job Growth
by Kevin Matras
Kevin Matras goes over how to find winning stock-picking ideas in the government's 'boring' economic reports. Highlighted stocks include DG, UFPI, JNJ, TXRH and DEI.
MedTech Industry Stock Outlook - March 2015
by Zacks Equity Research
Emerging market expansion, positive demographic trends and new product innovation have been the vital forces behind the continued uptrend of the sector's performance.